Navigation Links
Vion Pharmaceuticals Enters into Agreement to Conduct a Phase I/II Clinical Trial of Cloretazine(R) in Combination with Induction Therapy in Poor Prognosis AML Patients
Date:9/22/2008

i-Calmettes has been able to keep a humanist approach to its mission by putting patients at the heart of the treatments and decisions that concern them. Each year, more than 1,200 staff members treat over 19,000 patients at the Institut. Research activities are undertaken by a critical mass of more than 200 scientific staff personnel.

About GOELAMS

The GOELAMS is a large multi-center cooperative group that includes 49 centers in France. The focus of the group is clinical and translational research on acute leukemia and lymphomas. The group is involved in many academic clinical trials and also sponsors some trials. It has set up a network of biologists in order to facilitate the use of new technologies and biologic markers in a multi-center setting, as well as a centralized cell repository. The trial described above is part of a large AML frontline therapy program. Two Phase III trials are currently ongoing for patients with favorable and intermediate-risk AML.

This news release contains forward-looking statements. Such statements are subject to certain risk factors which may cause Vion's plans to differ or results to vary from those expected, including Vion's potential inability to file a New Drug Application or obtain regulatory approval for its products, particularly laromustine (Cloretazine (VNP40101M)), delayed or unfavorable results of drug trials, the possibility that favorable results of earlier preclinical studies, clinical trials or interim clinical trial data are not predictive of safety and efficacy results in later or final clinical trials, the need for additional research and testing, the inability to manufacture product, the potential inability to secure external sources of funding to continue operations, the inability to access capital and funding on favorable terms, continued operating losses and the inability to continue operations as a result, the delisting of the Company's common stock from the Nasdaq Capital Market and a vari
'/>"/>

SOURCE Vion Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... The global insulin market is ... new study by Grand View Research, Inc. Growing global prevalence of ... unmet needs in emerging markets such as India ... two of the most significant growth drivers of this market. Moreover, ... growing global geriatric population base are expected to serve the global ...
(Date:6/29/2015)... 2015  Sorrento Therapeutics, Inc. (NASDAQ: SRNE ; ... the Russell 2000® Small Cap, Russell 3000®, and Russell ... the close of trading on June 26, 2015 when ... U.S. and global indexes. Sorrento is already a member ... the Russell Indexes. Russell indexes are ...
(Date:6/29/2015)... SOUTH EASTON, Mass. , June 29, 2015 ... the "Company"), a leader in the development and ... sample preparation solutions to the worldwide life sciences ... of the Institute of Molecular Systems Biology, ETH ... the proteomic profiling and classification of prostate cancer ...
Breaking Medicine Technology:Insulin Market To Reach $47.54 Billion By 2020: Grand View Research, Inc. 2Insulin Market To Reach $47.54 Billion By 2020: Grand View Research, Inc. 3Insulin Market To Reach $47.54 Billion By 2020: Grand View Research, Inc. 4Sorrento Added to Russell 2000 Small Cap, Russell 3000 and Global Indexes 2Sorrento Added to Russell 2000 Small Cap, Russell 3000 and Global Indexes 3Better Classification of Prostate Cancer Tissue Biopsy Samples Enabled by Pressure BioSciences' PCT Platform 2Better Classification of Prostate Cancer Tissue Biopsy Samples Enabled by Pressure BioSciences' PCT Platform 3Better Classification of Prostate Cancer Tissue Biopsy Samples Enabled by Pressure BioSciences' PCT Platform 4
... to be delivered at the Drug Information Association (DIA) ... Geneva, Switzerland, experts from PAREXEL International Corporation ... services provider, will address advanced approaches to help the ... Experts from PAREXEL will be available at ...
... DUBLIN, Ireland, March 4, 2011 Warner Chilcott plc (Nasdaq: ... President and Chief Financial Officer Paul Herendeen is scheduled to ... Tuesday, March 8th at 12:35 p.m. ET.   ... , with an archived replay of the webcast available shortly ...
Cached Medicine Technology:PAREXEL Experts to Present Advanced Approaches to Accelerate Development, Maximize Product Value at DIA EuroMeeting 2PAREXEL Experts to Present Advanced Approaches to Accelerate Development, Maximize Product Value at DIA EuroMeeting 3PAREXEL Experts to Present Advanced Approaches to Accelerate Development, Maximize Product Value at DIA EuroMeeting 4
(Date:6/30/2015)... ... , ... It has become fairly common to purchase fresh broccoli at the ... before cooking. Throwing out radish greens, beet leaves and chard stalks is pretty typical, ... takes a little knowledge and practice to use them. Josie's Organics is ...
(Date:6/30/2015)... ... June 30, 2015 , ... Skin Brushing (also known as Body Brushing) is a wonderful daily ... beautiful as it is more exposed to the elements. , Dry Skin Brushing takes only ... Exfoliate the dead cells and toxins on skin's surface. Skin is the largest organ ...
(Date:6/30/2015)... ... June 30, 2015 , ... Lecrae is quickly developing into one ... Rolling Stone and The New York Times to Billboard Magazine and Variety, among others. ... of the many reasons why so many people are taking notice. , “We are ...
(Date:6/30/2015)... ... June 30, 2015 , ... Medflow, the ... a SaaS electronic health records system from the company exclusively dedicated to helping ... 2.0 delivers an intuitive state-of-the-art solution combining modern cloud technology with Medflow’s proven ...
(Date:6/30/2015)... ... June 30, 2015 , ... “It is never too ... SunGrubbies.com. “We are particularly interested in getting the word out to children because ... surface. We are extremely pleased with our new video which we feel ...
Breaking Medicine News(10 mins):Health News:Whole Vegetable Cooking for Home Cooks: Josie's Organics Encourages Using All Parts of Vegetables – from Root to Stalk – Every Day 2Health News:Whole Vegetable Cooking for Home Cooks: Josie's Organics Encourages Using All Parts of Vegetables – from Root to Stalk – Every Day 3Health News:Whole Vegetable Cooking for Home Cooks: Josie's Organics Encourages Using All Parts of Vegetables – from Root to Stalk – Every Day 4Health News:Back in Stock: Keep Skin and Lymphatic System Healthy with Dry Skin Brushes from Sublime Beauty® 2Health News:Hands of Hope to Present Grammy Award-Winner Lecrae in Concert this August 2Health News:Hands of Hope to Present Grammy Award-Winner Lecrae in Concert this August 3Health News:Medflow Launches MEDFLOW 2.0 EHR – The Cloud-Based Ophthalmology EHR 2Health News:SunGrubbies.com, a Leading Online Retailer of Sun Protection Products, Joins Effort to Promote Sun Safety 2Health News:SunGrubbies.com, a Leading Online Retailer of Sun Protection Products, Joins Effort to Promote Sun Safety 3
... -- Compared to people who don,t smoke, smokers face twice ... that stroke nearly a decade sooner, a Canadian study finds. ... for stroke or heart disease drops to non-smoker levels, the ... deputy director of the Canadian Stroke Network (CSN), in a ...
... 3, 2011 A higher dose of radiation (74 Gy) ... that has spread to the lymph nodes, compared to the ... of a late-breaking randomized study presented at the plenary session, ... Society for Radiation Oncology (ASTRO). "Most radiation oncologists and ...
... HealthDay Reporter , MONDAY, Oct. 3 (HealthDay News) ... general anesthesia may be up to three times more likely ... they grow up, a new study suggests. However, experts ... small children who require more than one surgery. "A ...
... Oct. 3, 2011 Dr. Bruce A. Beutler, the ... Defense at UT Southwestern Medical Center, today shared the Nobel ... their discoveries in how the immune system works. ... Institut de Biologie Molculaire et Cellulaire in France shared half ...
... in Spanish . Roger Gomis, ICREA researcher ... up the spin-off Supragen. With the support of IRB Barcelona and ... is the second biotech company to emerge from the institute since ... the end of 2005. Supragen seeks to develop a diagnostic kit ...
... (HealthDay News) -- People who are easily embarrassed are more ... to a new study. "Moderate levels of embarrassment are ... doctoral student in psychology at the University of California, Berkeley, ... is a good thing, not something you should fight." ...
Cached Medicine News:Health News: Smoking May Double Risk for Stroke 2Health News:Higher radiation dose does not help lung cancer patients live longer 2Health News:Could Surgery, Anesthesia While Very Young Hamper Kids' Development? 2Health News:Could Surgery, Anesthesia While Very Young Hamper Kids' Development? 3Health News:UT Southwestern scientist shares 2011 Nobel Prize in Physiology or Medicine 2Health News:UT Southwestern scientist shares 2011 Nobel Prize in Physiology or Medicine 3Health News:IRB Barcelona spin-off to develop a diagnostic kit and new treatments for metastasis 2Health News:Why It's Good If You're Easily Embarrassed 2
... offers reliable microhematocrit determinations. Although the Microspin ... more affordable than most competitive 6 tube ... spin-downs, and the included reader is adjustable, ... circumstances. Offering quieter operation than many similiar ...
... Pelvic surgery represents one of the ... The Matta Pelvic Plating System offers the ... system for addressing fractures of the pelvis ... world renowned as a premiere pelvic surgeon, ...
Comprehensive range of integrated implants and instruments including - Basic, Small, Mini, Pelvic and Foot Sets....
... Conforming to U.S. and international ... Nephew's TC-100 Screw and Plating System* ... and ease of use for open ... However, the TC-100 system works well ...
Medicine Products: